Home page image 1

Newly Diagnosed?

Man Receiving News from a doctor

Got questions about prostate cancer? Need support? You are not alone.

Start here. >

Meetings & Events

Circling a date on a calendar

Next Meeting

After two long years of COVID restrictions, finally we can celebrate – it’s our annual PCSO barbecue!

Learn more about PCS Ottawa meetings & events. >

Become a Member

Welcoming hands

Are you a prostate cancer patient or survivor, spouse or family member, caregiver, or supporter in the fight against prostate cancer?

Join now. >

What's New

Our First In-Person Meeting in Over 2½ Years!

Mark your calendars for 15 September 2022!  All are welcome to join us at St Stephen’s Anglican Church, 930 Watson St, for our first in-person general meeting since March 2019.

Read more >

Prostate Cancer Support Canada Newsletter August 2022

Check out the Prostate Cancer Support Canada Your Monthly Debrief for the latest in national-level news, webinars, meetings and events for July 2022.  Check the Debrief on how to register for the 2022 Prostate Cancer Virtual Conference & Expo 17-18 September 2022.

Read more This link goes to an external website

Ottawa Regional Cancer Foundation – Community Cancer Hub

After recently ending its long-running Cancer Coaching program, the Ottawa Regional Cancer Foundation has implemented its new Community Cancer Hub model of support.  Through its Cancer System Navigator, this program offers cancer patients and their families in Eastern Ontario a central contact point for referrals to both clinical care providers and community-based programs.

Read more >

New Survey on the use of darolutamide in the treatment of metastatic castration-sensitive prostate cancer

The Canadian Cancer Society is conducting a survey on the advantages and disadvantages of the drug darolutamide for treating metastatic castration-sensitive prostate cancer.  Patients and caregivers do not have to have experience with the drug to complete the survey, as information on their satisfaction with current treatments is valuable on its own.  Survey participants also may have an opportunity to give testimonials or be interviewed about their experience with darolutamide or their current treatments.  Results of the survey could lead to recommendations for darolutamide to be covered in Canada on public drug plans for people with this subset of prostate cancer. For information on participating in this survey, continue below.

Read more >

You’re Invited to Participate!

The University of Ottawa Psychosocial Oncology Laboratory is conducting two important cancer-related studies. Dr. Sophie Lebel and her doctoral students are seeking volunteers for their research in these two areas:

Read more >

News Archives >
Year-end 2021

Year-end 2021

The Walnut is the official newsletter for PCS Ottawa, currently published approximately four times a year.

Recent issue

We thank you for your continued support!